WELBIO is an inter-university life sciences research institute based in Wallonia, Belgium. WELBIO aims at promoting scientific excellence in fundamental life sciences research and translating scientific achievements in medical, pharmaceutical and veterinary biotechnology applications. 

NEWS

How the gut bacterium Akkermansia muciniphila affects diet-induced obesity

14/05/2013 - In a study published in Proceedings of the National Academy of Sciences USA, researchers lead by Patrice Cani, WELBIO investigator at the Université catholique de Louvain (UCL), Belgium, report how the gut bacterium Akkermansia muciniphila may play a crucial role in maintaining the gut mucosal barrier and in preventing obesity-related metabolic disorders. Read more...

Miikka Vikkula and Laurence Boon, recipients of the 2013 Prize for Clinical Research from the InBev-Baillet Latour Foundation

17/04/2013 – Miikka Vikkula (WELBIO investigator at the Catholic University of Louvain - UCML) and Laurence Boon (Clinique universitaires Saint-Luc) received this prestigious prize in recognition for their scientific research in vascular anomalies and lymphedema. Vascular anomalies are localized defects of vascular and/or lymphatic vessels with various presentations. Up to 10% of the population is affected, mostly due to the commonness of infantile hemangioma.  Read more...

All news